HPV is the leading cause of cervical cancer, which is curable in nearly 100 percent of cases when diagnosed early. Speaking about the HPV vaccine, which significantly reduces the risk of cervical cancer, obstetrician-gynecologist Prof. Dr. Çiğdem Yayla Abide says: “Many women think they are too late for the HPV vaccine and that it can only be given at a very young age. There is no upper age limit for the HPV vaccine.”

HPV causes no problems or symptoms in some people, while in others it leads to genital warts, and if left untreated for many years it can turn into cancer. According to epidemiological studies over the last 10 years, it is the most common sexually transmitted infection worldwide. Emphasizing that many people do not know they have HPV even though it is a very common disease, obstetrician-gynecologist Prof. Dr. Çiğdem Yayla Abide stresses the need for regular Pap smear and HPV DNA screening tests. It is estimated that more than 80 percent of sexually active women and men will contract at least one HPV infection by the age of 45. In addition to cervical cancer, HPV can also cause cancers of the vulva, vagina and anus, and even oropharyngeal (mouth, pharynx, larynx) and skin cancers.

According to World Health Organization data, an estimated 625,600 women and 69,400 men worldwide develop HPV-related cancer every year. In 2020, cervical cancer was the fourth leading cause of cancer and cancer deaths among women. Abide says: “Although cervical cancer is very common, it is expected to be eradicated in the coming years thanks to a range of measures. The World Health Organization is working very hard on this. Vaccination and screening programs are essential to reaching this goal.”

The HPV vaccine is one of the factors that significantly reduce the risk of cervical cancer. Vaccination before exposure to HPV provides the broadest protection. Abide adds: “Many women think they are too late for the HPV vaccine and that it can only be given at a very young age or in childhood. In some countries, the vaccine is recommended for all individuals, women and men, aged 9 and over (with no upper age limit), while in others it is recommended for individuals aged 9–45. The most effective age range is stated to be under 26. For people at high risk of recurrence after treatment because of HPV-related disease or immunodeficiency, the vaccine is recommended regardless of age.”

Abide explains that the vaccine is given as 2 doses up to age 15, and as 3 doses after age 15, at months 0, 2 and 6, and notes that studies have shown the vaccine remains effective for more than 10 years in women vaccinated between the ages of 27 and 45.

THE VACCINE CAN STILL HELP EVEN IF YOU HAVE ALREADY HAD HPV

More than 200 types of HPV have been identified; the most common, low-risk types are known to be HPV 6 and 11. Among these 200 types, two in particular, HPV 16 and 18, are held responsible for 70 percent of cervical cancers.

Three types of HPV vaccine are available in our country: the bivalent vaccine, which protects against types 16 and 18; the quadrivalent vaccine, which protects against types 6, 11, 16 and 18; and the 9-valent vaccine, which protects against types 6, 11, 16, 18, 31, 33, 45, 52 and 58. The 9-valent vaccine, which has the broadest coverage and the highest level of protection, is the most widely recommended.

Noting that many people who have contracted HPV come to ask about the vaccine, Abide says: “Vaccines are not helpful in treating lesions, because the purpose of the vaccine is to act against the virus before it enters the cell. In some cases, however, the vaccine is protective. For example, if you are positive for type 16, we recommend getting vaccinated because the vaccine can protect you against type 18. In other words, if you have not contracted a virus type included in the vaccine, the vaccine will protect you against it.”

Noting that side effects are one of the most frequently asked questions about the vaccine, Abide says: “To date, the vaccine has no proven serious side effects. Because the vaccine does not contain any live virus or viral DNA, it does not cause cancer or other HPV-related diseases.”

Originally published at: Sağlıkta Yenilikler